Palliative management of dyspnea in advanced cancer

Current Opinion in Oncology

Volumn 11, Issue 4, 1999, Pages 250-254

  LeGrand, Susan B ^a   Walsh, Declan ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; BENZODIAZEPINE DERIVATIVE; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; BUSPIRONE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DEXAMETHASONE; METHYLXANTHINE; MORPHINE; OPIATE; PHENOTHIAZINE DERIVATIVE; THEOPHYLLINE;

ADVANCED CANCER; ANXIETY NEUROSIS; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CELL; DYSPNEA; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; ORAL DRUG ADMINISTRATION; OXYGEN THERAPY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; SYMPTOM;

DYSPNEA; HUMANS; NEOPLASMS; PALLIATIVE CARE;

EID: 0033036615     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-199907000-00003     Document Type: Review

References (35)

1. 1 Muers MF, Round CE: Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organization Thoracic Group. Thorax 1993, 48:339-343.
2. 2 Donnelly S, Walsh D: The symptoms of advanced cancer. Semin Oncol 1995, 22:72-76.
3. 3 Brucra E, Neumann C: Management of specific symptom complexes in patients receiving palliative care. CMAJ 1998, 13:1717-1726.
4. 4 Ripamonti C, Fulfaro F, Bruera E: Dyspnea in patients with advanced cancer: incidence, causes and treatments. Cancer Treat Rev 1998, 24:69-80. This article is a good general review that includes a discussion of treatable causes and appropriate interventions in addition to the palliative approaches outlined in this review.
5. 5 Saunders C: What's in a name? Palliat Med 1987, 1:57-61.
6. 6 Nelson KA, Walsh D, Sheehan FA: The cancer anorexia-cachexia syndrome. J Clin Oncol 1994, 12:213-225.
7. 7 Dudgeon D, Lertzman M: Dyspnea in the advanced cancer patient, J Pain Symptom Manage 1998, 16:212-219. This study describes prospectively factors contributing to dyspnea in a group of cancer patients. It is unique for the prospective approach and the thorough evaluation done in each individual.
8. 8 Ahmedzai, S: Palliation of respiratory symptoms. In Oxford Textbook of Palliative Medicine, edn 2 Edited by Doyle D, Hanks GWC, MacDonald N. New York: Oxford Medical; 1998:583-561.
9. 9 Escalante CP, Martin CG, Etling LS, Cantor SB, Harle TS, Price KJ, et al.: Dyspnea in cancer patients: etiology, resource utilization and survival. Implications in a managed care world. Cancer 1996, 78:1314-1319.
10. 10 Gift AG: Validation of a vertical visual analog scale as a measure of clinical dyspnea. Rehabil Nurs 1989, 14:323-325.
11. 11 Gift AG, Narsavage G: Validity of the numeric rating scale as a measure of dyspnea. Am J Crit Care 1998, 7:200-204.
12. 12 Borg GAV: Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982, 14:377-381.
13. 13 McGavin CR, Artvinli M, Naoe H, McHardy GJ: Dyspnea, disability and distance walked: comparison of estimates of exercise performance in respiratory disease. BMJ 1978, 2:241-243.
14. 14 Ripamonti C, Bruera E: Dyspnea: pathophysiology and assessment. J Pain Symptom Manage 1997, 13:220-232.
15. 15 Congleton J, Muers MF: The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy, Respir Med 1995, 89:291-296.
16. 16 Brucra E, MacEachern T, Ripamonti C, Hanson J: Subcutaneous morphine for dyspnea in cancer patients. Ann Intern Med 119:906-907.
17. 17 Cohen MH, Anderson, AJ, Krasnow SH, Spagnolo SV, Citron ML, Payne M, Fossieck BE: Continuous infusion of morphine for severe dyspnea. South Med J 84:229-234.
18. 18 Bruera E, Macmillan K, Pither J, MacDonald RM: Effects of morphine on the dyspnea of terminal cancer patients. J Pain Symptom Manage 1990, 5:341-344.
19. 19 Poole P, Veale AG, Black PN: The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157:1877-1880.
20. 20 Boyd KJ, Kelly M: Oral morphine as symptomatic treatment of dyspnea in patients with advanced cancer. Palliat Med 1997, 11:277-281.
21. 21 Davis CL, Lam W, Roberts M, Daniels J, Joel SP, Slevin ML: The pharmacokinetics of nebulized morphine [Abstract 995]. In Proceedings of the International Association for the Study of Pain. Seattle: IASP Publications; 1993:379.
22. 22 Zeppetella G: Nebulized morphine in the palliation of dyspnea. Palliat Med 1997, 11:267-275.
23. 23 Davis C: The role of nebulized drugs in palliating respiratory symptoms in malignant disease. Eur J Palliat Care 1995, 2:9-15.
24. 24 Famcombe M, Chater S: Clinical application of nebulized opioids for treatment of dyspnea in patients with malignant disease. Support Care Cancer 1994, 2:184-187.
25. 25 Famcombe M, Chater S, Gillis A: The use of nebulized opioids for breathlessness: a chart review. Palliat Med 1994, 8:306-312.
26. 26 Lang E, Jedeikin R: Acute respiratory depression as a complication of nebulized morphine. Can J Anaesth 1998, 45(1):60-62.
27. 27 Argyropoulou P, Patakas D, Koukou A, Vasiliadis P, Georgopoulos D: Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease. Respiration 1993, 60:21 6-220.
28. 28 Singh NP, Despars JA, Stansbury DW, Avalos K, Light RW: Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety. Chest 1993, 103:800-804.
29. 29 Neill PA, Morton PB, Stark RD: Chlorpromazine: a specific effect on breathlessness? Br J Clin Pharmacol 1985, 19:793-797.
30. 30 Bruera E, de Stoutz N, Velasco-Leiva A, Schoeller T, Hanson J; Effects of oxygen on dyspnea in hypoxemic terminal-cancer patients. Lancet 1993,342:13-14.
31. 31 Booth S, Kelly MJ, Cox NP, Adams L, Guz A: Does oxygen help dyspnea in patients with cancer? Am Rev Respir Crit Care Med 1996, 153:1515-1518.
32. 32 Barach AL: Chronic obstructive lung disease: postural relief of dyspnea. Arch Phys Med Rehabil 1974, 55:494-504.
33. 33 Burgess KR, Whitelaw WA: Effects of nasal cold receptors on pattern of breathing. J Appl Physiol 1988, 64:371-376.
34. 34 Corner J, Plant H, A'Hern R, Bailey C: Non-pharmacological intervention for breathlessness in lung cancer. Palliat Med 1996, 10:299-305.
35. 35 Filshie J, Penn K, Ashley S, Davis CL: Acupuncture for the relief of cancer-related breathlessness. Palliat Med 1996, 10:145-150.